Finance

Lists
Why is INMB down 5.46%?
Dive Deeper
INMB:NASDAQ
INmune Bio Inc
$1.04
-5.46%
(-0.060) 1D
Nov 12, 2:02:43 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INMB...
Open
$1.10
High
$1.10
Low
$1.01
Mkt. cap
32.19M
Avg. vol.
298.78K
Volume
242.72K
52-wk high
$2.60
52-wk low
$1.01
EPS
-$0.62
Beta
0.97
Shares outstanding
30.96M
No. of employees
21
Open
$1.10
High
$1.10
Low
$1.01
Mkt. cap
32.19M
Avg. vol.
298.78K
Volume
242.72K
52-wk high
$2.60
52-wk low
$1.01
EPS
-$0.62
Beta
0.97
Shares outstanding
30.96M
No. of employees
21
News stories
From web sources and news partners
About INmune Bio Inc
CEO-
Employees21
Founded2015
HeadquartersBoca Raton, Florida, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to INMB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INMB in the last 3 months
Highest
Current $1.04
$8.00 (+669.30%)
Average
$8.00 (+669.30%)
Lowest
$8.00 (+669.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+669.3%
11/10/2026
James Molloy
Alliance Global Partners
Buy
Maintained
$7.00
+573.1%
04/06/2026
Elemer Piros
Lucid Capital
Buy
Upgraded
$9.00
+765.5%
03/11/2026
Thomas Shrader
BTIG
Hold
Maintained
-
-
11/03/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.56M
3.64M
-803.00K
3.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.92M
2.17M
2.28M
1.85M
Operating expense
5.47M
5.81M
1.48M
5.01M
Total operating expenses
5.47M
5.81M
1.48M
5.01M
Operating income
-5.47M
-5.81M
-1.48M
-5.01M
Other non operating income
-90.00K
405.00K
3.00K
287.00K
EBT including unusual items
-5.26M
-5.41M
-1.27M
-4.72M
EBT excluding unusual items
-5.26M
-5.41M
-1.27M
-4.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.26M
-5.41M
-1.27M
-4.72M
Net profit margin
-
-
-
-
Earnings per share
-0.18
-0.20
-0.05
-0.17
Interest and investment income
300.00K
-
200.00K
-
Interest expense
-
-
-
-
Net interest expenses
300.00K
-
200.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.42M
-5.76M
-1.41M
-4.94M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps